Antimicrobial resistance research in a post-pandemic world: Insights on antimicrobial resistance research in the COVID-19 pandemic

•Antibiotics have been used excessively in hospitalised COVID-19 patients.•COVID-19 has caused major disruptions to antimicrobial resistance surveillance and research.•Global data on the use of antibiotics during the COVID-19 pandemic are needed.•Antimicrobial resistance requires continued public an...

Celý popis

Uložené v:

Podrobná bibliografia
Vydané v:	JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE Ročník 25; s. 5 - 7
Hlavní autori:	Rodríguez-Baño, Jesús, Rossolini, Gian Maria, Schultsz, Constance, Tacconelli, Evelina, Murthy, Srinivas, Ohmagari, Norio, Holmes, Alison, Bachmann, Till, Goossens, Herman, Canton, Rafael, Roberts, Adam P., Henriques-Normark, Birgitta, Clancy, Cornelius J., Huttner, Benedikt, Fagerstedt, Patriq, Lahiri, Shawon, Kaushic, Charu, Hoffman, Steven J., Warren, Margo, Zoubiane, Ghada, Essack, Sabiha, Laxminarayan, Ramanan, Plant, Laura
Médium:	Journal Article
Jazyk:	English
Vydavateľské údaje:	Netherlands Elsevier Ltd 01.06.2021 Published by Elsevier Ltd. on behalf of International Society of Chemotherapy for Infection and Cancer Elsevier
Predmet:	Anti-Bacterial Agents - pharmacology Anti-Bacterial Agents - therapeutic use Antimicrobial resistance COVID-19 Drug Resistance, Bacterial Humans Infectious Disease Pandemics SARS-CoV-2 Stewardship Surveillance COVID-19 Stewardship Antimicrobial resistance Research Surveillance
ISSN:	2213-7165, 2213-7173, 2213-7165, 2213-7173
On-line prístup:	Získať plný text
Tagy:	Pridať tag Žiadne tagy, Buďte prvý, kto otaguje tento záznam!

Abstract	•Antibiotics have been used excessively in hospitalised COVID-19 patients.•COVID-19 has caused major disruptions to antimicrobial resistance surveillance and research.•Global data on the use of antibiotics during the COVID-19 pandemic are needed.•Antimicrobial resistance requires continued public and political engagement. Antimicrobial resistance must be recognised as a global societal priority - even in the face of the worldwide challenge of the COVID-19 pandemic. COVID-19 has illustrated the vulnerability of our healthcare systems in co-managing multiple infectious disease threats as resources for monitoring and detecting, and conducting research on antimicrobial resistance have been compromised during the pandemic. The increased awareness of the importance of infectious diseases, clinical microbiology and infection control and lessons learnt during the COVID-19 pandemic should be exploited to ensure that emergence of future infectious disease threats, including those related to AMR, are minimised. Harnessing the public understanding of the relevance of infectious diseases towards the long-term pandemic of AMR could have major implications for promoting good practices about the control of AMR transmission.
AbstractList	Antimicrobial resistance must be recognised as a global societal priority - even in the face of the worldwide challenge of the COVID-19 pandemic. COVID-19 has illustrated the vulnerability of our healthcare systems in co-managing multiple infectious disease threats as resources for monitoring and detecting, and conducting research on antimicrobial resistance have been compromised during the pandemic. The increased awareness of the importance of infectious diseases, clinical microbiology and infection control and lessons learnt during the COVID-19 pandemic should be exploited to ensure that emergence of future infectious disease threats, including those related to AMR, are minimised. Harnessing the public understanding of the relevance of infectious diseases towards the long-term pandemic of AMR could have major implications for promoting good practices about the control of AMR transmission. •Antibiotics have been used excessively in hospitalised COVID-19 patients.•COVID-19 has caused major disruptions to antimicrobial resistance surveillance and research.•Global data on the use of antibiotics during the COVID-19 pandemic are needed.•Antimicrobial resistance requires continued public and political engagement. Antimicrobial resistance must be recognised as a global societal priority - even in the face of the worldwide challenge of the COVID-19 pandemic. COVID-19 has illustrated the vulnerability of our healthcare systems in co-managing multiple infectious disease threats as resources for monitoring and detecting, and conducting research on antimicrobial resistance have been compromised during the pandemic. The increased awareness of the importance of infectious diseases, clinical microbiology and infection control and lessons learnt during the COVID-19 pandemic should be exploited to ensure that emergence of future infectious disease threats, including those related to AMR, are minimised. Harnessing the public understanding of the relevance of infectious diseases towards the long-term pandemic of AMR could have major implications for promoting good practices about the control of AMR transmission. Antimicrobial resistance must be recognised as a global societal priority - even in the face of the worldwide challenge of the COVID-19 pandemic. COVID-19 has illustrated the vulnerability of our healthcare systems in co-managing multiple infectious disease threats as resources for monitoring and detecting, and conducting research on antimicrobial resistance have been compromised during the pandemic. The increased awareness of the importance of infectious diseases, clinical microbiology and infection control and lessons learnt during the COVID-19 pandemic should be exploited to ensure that emergence of future infectious disease threats, including those related to AMR, are minimised. Harnessing the public understanding of the relevance of infectious diseases towards the long-term pandemic of AMR could have major implications for promoting good practices about the control of AMR transmission.Antimicrobial resistance must be recognised as a global societal priority - even in the face of the worldwide challenge of the COVID-19 pandemic. COVID-19 has illustrated the vulnerability of our healthcare systems in co-managing multiple infectious disease threats as resources for monitoring and detecting, and conducting research on antimicrobial resistance have been compromised during the pandemic. The increased awareness of the importance of infectious diseases, clinical microbiology and infection control and lessons learnt during the COVID-19 pandemic should be exploited to ensure that emergence of future infectious disease threats, including those related to AMR, are minimised. Harnessing the public understanding of the relevance of infectious diseases towards the long-term pandemic of AMR could have major implications for promoting good practices about the control of AMR transmission. Highlights•Antibiotics have been used excessively in hospitalised COVID-19 patients. •COVID-19 has caused major disruptions to antimicrobial resistance surveillance and research. •Global data on the use of antibiotics during the COVID-19 pandemic are needed. •Antimicrobial resistance requires continued public and political engagement. • Antibiotics have been used excessively in hospitalised COVID-19 patients. • COVID-19 has caused major disruptions to antimicrobial resistance surveillance and research. • Global data on the use of antibiotics during the COVID-19 pandemic are needed. • Antimicrobial resistance requires continued public and political engagement. Antimicrobial resistance must be recognised as a global societal priority - even in the face of the worldwide challenge of the COVID-19 pandemic. COVID-19 has illustrated the vulnerability of our healthcare systems in co-managing multiple infectious disease threats as resources for monitoring and detecting, and conducting research on antimicrobial resistance have been compromised during the pandemic. The increased awareness of the importance of infectious diseases, clinical microbiology and infection control and lessons learnt during the COVID-19 pandemic should be exploited to ensure that emergence of future infectious disease threats, including those related to AMR, are minimised. Harnessing the public understanding of the relevance of infectious diseases towards the long-term pandemic of AMR could have major implications for promoting good practices about the control of AMR transmission.
Author	Warren, Margo Rodríguez-Baño, Jesús Ohmagari, Norio Clancy, Cornelius J. Rossolini, Gian Maria Hoffman, Steven J. Tacconelli, Evelina Henriques-Normark, Birgitta Lahiri, Shawon Kaushic, Charu Zoubiane, Ghada Roberts, Adam P. Huttner, Benedikt Bachmann, Till Goossens, Herman Laxminarayan, Ramanan Murthy, Srinivas Holmes, Alison Essack, Sabiha Plant, Laura Canton, Rafael Schultsz, Constance Fagerstedt, Patriq
Author_xml	– sequence: 1 givenname: Jesús surname: Rodríguez-Baño fullname: Rodríguez-Baño, Jesús organization: Unidad Clínica de Enfermedades Infecciosas, Microbiología y Medicina Preventiva, Hospital Universitario Virgen Macarena, Seville, Spain – sequence: 2 givenname: Gian Maria surname: Rossolini fullname: Rossolini, Gian Maria organization: Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy – sequence: 3 givenname: Constance surname: Schultsz fullname: Schultsz, Constance organization: Department of Global Health–AIGHD Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands – sequence: 4 givenname: Evelina surname: Tacconelli fullname: Tacconelli, Evelina organization: Division of Infectious Diseases, Department of Diagnostic and Public Health, University of Verona, Verona, Italy – sequence: 5 givenname: Srinivas surname: Murthy fullname: Murthy, Srinivas organization: BC Children’s Hospital, University of British Columbia, Vancouver, Canada – sequence: 6 givenname: Norio surname: Ohmagari fullname: Ohmagari, Norio organization: Disease Control and Prevention Center, National Center for Global Health and Medicine, Tokyo, Japan – sequence: 7 givenname: Alison surname: Holmes fullname: Holmes, Alison organization: Department of Medicine, Faculty of Medicine, Imperial College London, London, UK – sequence: 8 givenname: Till surname: Bachmann fullname: Bachmann, Till organization: The University of Edinburgh, Edinburgh Medical School, Division of Infection and Pathway Medicine, The Chancellor’s Building, Edinburgh, UK – sequence: 9 givenname: Herman surname: Goossens fullname: Goossens, Herman organization: Laboratory of Medical Microbiology, Vaccine & Infectious Disease Institute, University of Antwerp, Antwerp, Belgium – sequence: 10 givenname: Rafael surname: Canton fullname: Canton, Rafael organization: Servicio de Microbiología, Hospital Universitario Ramón y Cajal and Instituto Ramón y Cajal de Investigación Sanitaria, Madrid, Spain – sequence: 11 givenname: Adam P. surname: Roberts fullname: Roberts, Adam P. organization: Department of Tropical Disease Biology, Liverpool School of Tropical Medicine, Pembroke Place, Liverpool, UK – sequence: 12 givenname: Birgitta surname: Henriques-Normark fullname: Henriques-Normark, Birgitta organization: Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden – sequence: 13 givenname: Cornelius J. surname: Clancy fullname: Clancy, Cornelius J. organization: University of Pittsburgh, 3550 Terrace St., Scaife Hall 867, Pittsburgh, PA, USA – sequence: 14 givenname: Benedikt surname: Huttner fullname: Huttner, Benedikt organization: Division of Infectious Diseases, Geneva University Hospitals, Faculty of Medicine, University of Geneva, Geneva, Switzerland – sequence: 15 givenname: Patriq surname: Fagerstedt fullname: Fagerstedt, Patriq organization: JPIAMR Secretariat, Swedish Research Council, Stockholm, Sweden – sequence: 16 givenname: Shawon surname: Lahiri fullname: Lahiri, Shawon organization: JPIAMR Secretariat, Swedish Research Council, Stockholm, Sweden – sequence: 17 givenname: Charu surname: Kaushic fullname: Kaushic, Charu organization: Institute of Infection and Immunity, Canadian Institutes of Health Research, Canada – sequence: 18 givenname: Steven J. surname: Hoffman fullname: Hoffman, Steven J. organization: Global Strategy Lab, Dahdaleh Institute for Global Health Research, School of Global Health and Osgoode Hall Law School, York University, Toronto, Canada – sequence: 19 givenname: Margo surname: Warren fullname: Warren, Margo organization: Access to Medicine Foundation, Naritaweg 227-A, 1043 CB, Amsterdam, The Netherlands – sequence: 20 givenname: Ghada surname: Zoubiane fullname: Zoubiane, Ghada organization: International Centre for Antimicrobial Resistance Solutions (ICARS), Copenhagen, Denmark – sequence: 21 givenname: Sabiha surname: Essack fullname: Essack, Sabiha organization: International Centre for Antimicrobial Resistance Solutions (ICARS), Copenhagen, Denmark – sequence: 22 givenname: Ramanan surname: Laxminarayan fullname: Laxminarayan, Ramanan organization: Center for Disease Dynamics, Economics & Policy, New Delhi, India – sequence: 23 givenname: Laura surname: Plant fullname: Plant, Laura email: Laura.Plant@vr.se organization: Institute of Infection and Immunity, Canadian Institutes of Health Research, Canada
BackLink	https://www.ncbi.nlm.nih.gov/pubmed/33662647$$D View this record in MEDLINE/PubMed http://kipublications.ki.se/Default.aspx?queryparsed=id:147043591$$DView record from Swedish Publication Index (Karolinska Institutet)
BookMark	eNqNkktvEzEUhUeoiJbSP8ACzZLNBL89U6FKVXhFqtQFD7GzXM-dxNOJHWynVbf8cjwkQU0lCt74yj7nu7LveV4cOO-gKF5iNMEIizf9pJ_rMCGI4AkiE4Tpk-KIEEwriQU_uFcfFicx9iivhmEi5LPikFIhiGDyqPh57pJdWhP8ldVDGSDamLQzMJagg1mU1pW6XPmYqpV2LWRxeevD0J6WMxftfJFi6bPkfzhpAeX08tvsXYWbckd7UTzt9BDhZLsfF18_vP8y_VRdXH6cTc8vKiMpTlVby5ZygI5qg7CkrAaUnwCNxg3wljNNtJCd4VB3FLhkGnfINJJ0NZXYCHpczDbc1uterYJd6nCnvLbq94EPc6VDsmYApXXLgUksdd4aaOsGs1oKjIjoaM0hs6oNK97Can21R9seXecKFBO0ZjLrzzb6fLOE1oBLQQ97tv0bZxdq7m-UbHDDMc-A11tA8D_WEJNa2mhgGLQDv46KsKZmDeYCZemr-73-NNkNPQvqjSBPK8YAnTI26WT92NoOCiM1Rkz1aoyYGiOmEFE5YtlKHlh39EdNbzcmyNO9sRBUNBZyNlobwKT8_fZx-9kDuxmss0YP13AHsffr4HJuFFYxG9TnMfhj7gnOkWf8ewac_h3wr-6_ANPSFHg
CitedBy_id	crossref_primary_10_1002_jcla_24959 crossref_primary_10_1097_JS9_0000000000001165 crossref_primary_10_3389_fsufs_2022_819158 crossref_primary_10_1016_j_ijregi_2024_100381 crossref_primary_10_3390_jpm13071035 crossref_primary_10_1016_j_molstruc_2022_132811 crossref_primary_10_1016_j_jhin_2021_04_030 crossref_primary_10_1016_j_jinf_2021_09_016 crossref_primary_10_3390_antibiotics13090823 crossref_primary_10_1016_j_biopha_2024_116723 crossref_primary_10_1186_s40545_022_00500_5 crossref_primary_10_1038_s41467_023_41156_2 crossref_primary_10_1007_s12668_025_02073_4 crossref_primary_10_1016_j_chemosphere_2022_136877 crossref_primary_10_7759_cureus_21035 crossref_primary_10_1016_j_jiph_2024_102490 crossref_primary_10_1186_s12941_021_00472_5 crossref_primary_10_3390_antibiotics12111600 crossref_primary_10_1002_open_202100260 crossref_primary_10_1038_s41598_021_95788_9 crossref_primary_10_3389_fpubh_2021_770593 crossref_primary_10_3390_antibiotics11060816 crossref_primary_10_1002_jac5_1622 crossref_primary_10_3390_antibiotics12030431 crossref_primary_10_1016_j_psep_2023_02_049 crossref_primary_10_1016_j_jiph_2022_12_022 crossref_primary_10_2174_0122113525295259240815073809 crossref_primary_10_3390_plants12233997 crossref_primary_10_1002_hsr2_771 crossref_primary_10_3390_antibiotics11020244 crossref_primary_10_3390_antibiotics12010151 crossref_primary_10_1186_s13756_024_01427_z crossref_primary_10_1038_s41598_025_08445_w
Cites_doi	10.1016/j.cmi.2020.07.041 10.1126/science.abc0035 10.1016/j.cmi.2020.07.016 10.1016/j.ijantimicag.2020.105946 10.1016/j.tmaid.2020.101878 10.1016/S2542-5196(18)30186-4 10.1213/ANE.0000000000004846 10.1093/cid/ciaa530
ContentType	Journal Article
Copyright	2021 The Authors The Authors Copyright © 2021 The Authors. Published by Elsevier Ltd.. All rights reserved. 2021 The Authors 2021
Copyright_xml	– notice: 2021 The Authors – notice: The Authors – notice: Copyright © 2021 The Authors. Published by Elsevier Ltd.. All rights reserved. – notice: 2021 The Authors 2021
DBID	6I. AAFTH AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 5PM ADTPV AOWAS D8T ZZAVC DOA
DOI	10.1016/j.jgar.2021.02.013
DatabaseName	ScienceDirect Open Access Titles Elsevier:ScienceDirect:Open Access CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic PubMed Central (Full Participant titles) SwePub SwePub Articles SWEPUB Freely available online SwePub Articles full text Directory of Open Access Journals
DatabaseTitle	CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic
DatabaseTitleList	MEDLINE MEDLINE - Academic
Database_xml	– sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database
DeliveryMethod	fulltext_linktorsrc
Discipline	Biology
EISSN	2213-7165 2213-7173
EndPage	7
ExternalDocumentID	oai_doaj_org_article_aad5e4717a5e49ed89148761026f385e oai_swepub_ki_se_463847 PMC7919515 33662647 10_1016_j_jgar_2021_02_013 S221371652100045X 1_s2_0_S221371652100045X
Genre	Research Support, Non-U.S. Gov't Journal Article
GrantInformation_xml	– fundername: Medical Research Council grantid: MR/S037640/1 – fundername: Medical Research Council grantid: MR/S004793/1
GroupedDBID	--M .1- .FO .~1 0R~ 1~. 4.4 457 4G. 53G 7-5 8P~ AAAJQ AABSN AAEDT AAEDW AAIKJ AAKOC AALRI AAOAW AAQFI AATTM AAXKI AAXUO AAYWO ABJNI ABMAC ABMZM ABXDB ACDAQ ACGFS ACIEU ACLOT ACRLP ACVFH ADBBV ADCNI ADEZE ADVLN AEBSH AEIPS AEKER AENEX AEUPX AFJKZ AFPUW AFRHN AFTJW AFXIZ AGEKW AGHFR AGLDT AGUBO AGYEJ AIEXJ AIGII AIIUN AIKHN AITUG AJRQY AJUYK AKBMS AKRWK AKYEP ALMA_UNASSIGNED_HOLDINGS AMRAJ ANKPU ANZVX APXCP AXJTR BKOJK BLXMC BNPGV CJTIS COPKO EBS EFJIC EFKBS EFLBG EJD FDB FEDTE FIRID FNPLU FYGXN GBLVA GROUPED_DOAJ HVGLF HZ~ KOM LUGTX M41 MO0 O-L O9- OAUVE OK1 P-8 P-9 PC. Q38 ROL SDF SPCBC SSH SSI SSZ T5K Z5R ~G- ~HD AACTN AAHOK AFCTW AFKWA AJOXV AMFUW NCXOZ RIG 6I. AAFTH AAIAV ABLVK ABYKQ AJBFU LCYCR AAYXX CITATION M~E AGCQF AGRNS CGR CUY CVF ECM EIF NPM 7X8 5PM ADTPV AOWAS D8T ZZAVC
ID	FETCH-LOGICAL-c731t-d87d35eef3ac017348e0647e9a19e5d54a2a67fc5e8f3e574a1f0c972f8371c63
IEDL.DBID	DOA
ISICitedReferencesCount	38
ISICitedReferencesURI	http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000664031300002&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN	2213-7165 2213-7173
IngestDate	Fri Oct 03 12:41:00 EDT 2025 Tue Nov 25 03:29:40 EST 2025 Tue Nov 04 02:04:53 EST 2025 Wed Oct 01 08:55:28 EDT 2025 Mon Jul 21 05:35:53 EDT 2025 Sat Nov 29 06:59:25 EST 2025 Tue Nov 18 22:25:28 EST 2025 Fri Feb 23 02:44:18 EST 2024 Tue Feb 25 20:01:04 EST 2025 Tue Oct 14 19:30:29 EDT 2025
IsDoiOpenAccess	true
IsOpenAccess	true
IsPeerReviewed	true
IsScholarly	true
Keywords	COVID-19 Stewardship Antimicrobial resistance Research Surveillance
Language	English
License	This is an open access article under the CC BY-NC-ND license. Copyright © 2021 The Authors. Published by Elsevier Ltd.. All rights reserved. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
LinkModel	DirectLink
MergedId	FETCHMERGED-LOGICAL-c731t-d87d35eef3ac017348e0647e9a19e5d54a2a67fc5e8f3e574a1f0c972f8371c63
Notes	ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23
OpenAccessLink	https://doaj.org/article/aad5e4717a5e49ed89148761026f385e
PMID	33662647
PQID	2498491560
PQPubID	23479
PageCount	3
ParticipantIDs	doaj_primary_oai_doaj_org_article_aad5e4717a5e49ed89148761026f385e swepub_primary_oai_swepub_ki_se_463847 pubmedcentral_primary_oai_pubmedcentral_nih_gov_7919515 proquest_miscellaneous_2498491560 pubmed_primary_33662647 crossref_citationtrail_10_1016_j_jgar_2021_02_013 crossref_primary_10_1016_j_jgar_2021_02_013 elsevier_sciencedirect_doi_10_1016_j_jgar_2021_02_013 elsevier_clinicalkeyesjournals_1_s2_0_S221371652100045X elsevier_clinicalkey_doi_10_1016_j_jgar_2021_02_013
PublicationCentury	2000
PublicationDate	2021-06-01
PublicationDateYYYYMMDD	2021-06-01
PublicationDate_xml	– month: 06 year: 2021 text: 2021-06-01 day: 01
PublicationDecade	2020
PublicationPlace	Netherlands
PublicationPlace_xml	– name: Netherlands
PublicationTitle	JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE
PublicationTitleAlternate	J Glob Antimicrob Resist
PublicationYear	2021
Publisher	Elsevier Ltd Published by Elsevier Ltd. on behalf of International Society of Chemotherapy for Infection and Cancer Elsevier
Publisher_xml	– name: Elsevier Ltd – name: Published by Elsevier Ltd. on behalf of International Society of Chemotherapy for Infection and Cancer – name: Elsevier
References	Langford, So, Raybardhan, Leung, Westwood, MacFadden (bib0010) 2020; 26 Collignon, Beggs, Walsh, Gandra, Laxminarayan (bib0045) 2018; 2 Rawson, Moore, Zhu, Ranganathan, Skolimowska, Gilchrist (bib0005) 2020; 71 Dubbink, Branco, Kamara, Bangura, Wehrens, Falama (bib0035) 2020; 37 Lai, Wang, Wang, Hsueh, Ko, Hsueh (bib0025) 2020; 55 Access to Medicine Foundation. Antimicrobial Resistance Benchmark 2020. [Accessed 2 March 2021]. Bong, Brasher, Chikumba, McDougall, Mellin-Olsen, Enright (bib0030) 2020; 131 Walker, Whittaker, Watson, Baguelin, Winskill, Hamlet (bib0040) 2020; 369 Garcia-Vidal, Sanjuan, Moreno-García, Martínez, Puerta-Alcade, Garcia-Pouton (bib0015) 2021; 27 Lai (10.1016/j.jgar.2021.02.013_bib0025) 2020; 55 Langford (10.1016/j.jgar.2021.02.013_bib0010) 2020; 26 10.1016/j.jgar.2021.02.013_bib0020 Collignon (10.1016/j.jgar.2021.02.013_bib0045) 2018; 2 Garcia-Vidal (10.1016/j.jgar.2021.02.013_bib0015) 2021; 27 Dubbink (10.1016/j.jgar.2021.02.013_bib0035) 2020; 37 Walker (10.1016/j.jgar.2021.02.013_bib0040) 2020; 369 Rawson (10.1016/j.jgar.2021.02.013_bib0005) 2020; 71 Bong (10.1016/j.jgar.2021.02.013_bib0030) 2020; 131
References_xml	– volume: 27 start-page: 83 year: 2021 end-page: 88 ident: bib0015 article-title: Incidence of co-infections and superinfections in hospitalized patients with COVID-19: a retrospective cohort study publication-title: Clin Microbiol Infect – volume: 55 start-page: 105946 year: 2020 ident: bib0025 article-title: Global epidemiology of coronavirus disease 2019 (COVID-19): disease incidence, daily cumulative index, mortality, and their association with country healthcare resources and economic status publication-title: Int J Antimicrob Agents – volume: 369 start-page: 413 year: 2020 end-page: 422 ident: bib0040 article-title: The impact of COVID-19 and strategies for mitigation and suppression in low- and middle-income countries publication-title: Science – volume: 71 start-page: 2459 year: 2020 end-page: 2468 ident: bib0005 article-title: Bacterial and fungal co-infection in individuals with coronavirus: a rapid review to support COVID-19 antimicrobial prescribing publication-title: Clin Infect Dis – reference: . [Accessed 2 March 2021]. – volume: 2 start-page: e398 year: 2018 end-page: 405 ident: bib0045 article-title: Anthropological and socioeconomic factors contributing to global antimicrobial resistance: a univariate and multivariable analysis publication-title: Lancet Planet Health – reference: Access to Medicine Foundation. Antimicrobial Resistance Benchmark 2020. – volume: 37 year: 2020 ident: bib0035 article-title: COVID-19 treatment in sub-Saharan Africa: if the best is not available, the available becomes the best publication-title: Travel Med Infect Dis – volume: 26 start-page: 1622 year: 2020 end-page: 1629 ident: bib0010 article-title: Bacterial co-infection and secondary infection in patients with COVID-19: a living rapid review and meta-analysis publication-title: Clin Microbiol Infect – volume: 131 start-page: 86 year: 2020 end-page: 92 ident: bib0030 article-title: The COVID-19 pandemic: effects on low- and middle-income countries publication-title: Anesth Analg – volume: 27 start-page: 83 year: 2021 ident: 10.1016/j.jgar.2021.02.013_bib0015 article-title: Incidence of co-infections and superinfections in hospitalized patients with COVID-19: a retrospective cohort study publication-title: Clin Microbiol Infect doi: 10.1016/j.cmi.2020.07.041 – volume: 369 start-page: 413 year: 2020 ident: 10.1016/j.jgar.2021.02.013_bib0040 article-title: The impact of COVID-19 and strategies for mitigation and suppression in low- and middle-income countries publication-title: Science doi: 10.1126/science.abc0035 – volume: 26 start-page: 1622 year: 2020 ident: 10.1016/j.jgar.2021.02.013_bib0010 article-title: Bacterial co-infection and secondary infection in patients with COVID-19: a living rapid review and meta-analysis publication-title: Clin Microbiol Infect doi: 10.1016/j.cmi.2020.07.016 – volume: 55 start-page: 105946 year: 2020 ident: 10.1016/j.jgar.2021.02.013_bib0025 article-title: Global epidemiology of coronavirus disease 2019 (COVID-19): disease incidence, daily cumulative index, mortality, and their association with country healthcare resources and economic status publication-title: Int J Antimicrob Agents doi: 10.1016/j.ijantimicag.2020.105946 – volume: 37 year: 2020 ident: 10.1016/j.jgar.2021.02.013_bib0035 article-title: COVID-19 treatment in sub-Saharan Africa: if the best is not available, the available becomes the best publication-title: Travel Med Infect Dis doi: 10.1016/j.tmaid.2020.101878 – volume: 2 start-page: e398 year: 2018 ident: 10.1016/j.jgar.2021.02.013_bib0045 article-title: Anthropological and socioeconomic factors contributing to global antimicrobial resistance: a univariate and multivariable analysis publication-title: Lancet Planet Health doi: 10.1016/S2542-5196(18)30186-4 – volume: 131 start-page: 86 year: 2020 ident: 10.1016/j.jgar.2021.02.013_bib0030 article-title: The COVID-19 pandemic: effects on low- and middle-income countries publication-title: Anesth Analg doi: 10.1213/ANE.0000000000004846 – volume: 71 start-page: 2459 year: 2020 ident: 10.1016/j.jgar.2021.02.013_bib0005 article-title: Bacterial and fungal co-infection in individuals with coronavirus: a rapid review to support COVID-19 antimicrobial prescribing publication-title: Clin Infect Dis doi: 10.1093/cid/ciaa530 – ident: 10.1016/j.jgar.2021.02.013_bib0020
SSID	ssj0000941267 ssib050733640
Score	2.3853605
Snippet	•Antibiotics have been used excessively in hospitalised COVID-19 patients.•COVID-19 has caused major disruptions to antimicrobial resistance surveillance and... Highlights•Antibiotics have been used excessively in hospitalised COVID-19 patients. •COVID-19 has caused major disruptions to antimicrobial resistance... Antimicrobial resistance must be recognised as a global societal priority - even in the face of the worldwide challenge of the COVID-19 pandemic. COVID-19 has... • Antibiotics have been used excessively in hospitalised COVID-19 patients. • COVID-19 has caused major disruptions to antimicrobial resistance surveillance...
SourceID	doaj swepub pubmedcentral proquest pubmed crossref elsevier
SourceType	Open Website Open Access Repository Aggregation Database Index Database Enrichment Source Publisher
StartPage	5
SubjectTerms	Anti-Bacterial Agents - pharmacology Anti-Bacterial Agents - therapeutic use Antimicrobial resistance COVID-19 Drug Resistance, Bacterial Humans Infectious Disease Pandemics SARS-CoV-2 Stewardship Surveillance
Title	Antimicrobial resistance research in a post-pandemic world: Insights on antimicrobial resistance research in the COVID-19 pandemic
URI	https://www.clinicalkey.com/#!/content/1-s2.0-S221371652100045X https://www.clinicalkey.es/playcontent/1-s2.0-S221371652100045X https://dx.doi.org/10.1016/j.jgar.2021.02.013 https://www.ncbi.nlm.nih.gov/pubmed/33662647 https://www.proquest.com/docview/2498491560 https://pubmed.ncbi.nlm.nih.gov/PMC7919515 http://kipublications.ki.se/Default.aspx?queryparsed=id:147043591 https://doaj.org/article/aad5e4717a5e49ed89148761026f385e
Volume	25
WOSCitedRecordID	wos000664031300002&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText	1
inHoldings	1
isFullTextHit
isPrint
journalDatabaseRights	– providerCode: PRVAON databaseName: DOAJ Directory of Open Access Journals customDbUrl: eissn: 2213-7165 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000941267 issn: 2213-7165 databaseCode: DOA dateStart: 20200101 isFulltext: true titleUrlDefault: https://www.doaj.org/ providerName: Directory of Open Access Journals – providerCode: PRVESC databaseName: ScienceDirect Freedom Collection - Elsevier customDbUrl: eissn: 2213-7165 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000941267 issn: 2213-7165 databaseCode: AIEXJ dateStart: 20200301 isFulltext: true titleUrlDefault: https://www.sciencedirect.com providerName: Elsevier – providerCode: PRVHPJ databaseName: ROAD: Directory of Open Access Scholarly Resources customDbUrl: eissn: 2213-7165 dateEnd: 99991231 omitProxy: false ssIdentifier: ssib050733640 issn: 2213-7165 databaseCode: M~E dateStart: 20130101 isFulltext: true titleUrlDefault: https://road.issn.org providerName: ISSN International Centre
link	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwEB5BAakXxLMNj5WREBcUEcdxHHNbylYsEgWJh_ZmeR1HzQLZVZMiceHAL2dsJ6tGRS0HLkmUjJ2NZzL-Jjv-BuCpzUuTl9bGdEllnNnExMsUFVK4nKgSIXlZGV9sQhwdFYuF_HCm1JfLCQv0wGHgXmhdcoseVGjcSVsWEgE8xt4YO1Ss4NZ5X0Q9Z4KpVciXo6kvH5umlMUYFPB-xUxI7lo5ileM-wNhJ2WjWcmT948mp_Pg83wO5Yhp1M9Oh7fgZg8ryTQ8zm24Yps7cCMUmvx5F35Pm67-XnvSJRTDENvBRtQ36cl-jkndEE0267aLN-67MgoTz6b6ksyb1kXwLVmjyL_0g5iSHLz_Mn8dU0mG3u7B58PZp4M3cV99ITaC0S4uC1Eybm3FtMHXlmWFdQtTrdRUWl7yTKc6F5XhtqiY5SLTtEqMFGmFMS81ObsPO826sftAECQyN1cmS-n4tWRhUsZExRAbyJzrJAI6jL4yPTW5q5DxTQ05aCvlNKacxlSSKtRYBM-3bTaBmONC6VdOqVtJR6rtT6Cpqd7U1GWmFgEbTEIN61bR02JH9YW3Fn9rZdveWbSKqhYl1Udnqs5SU-qR9iICvm3Z46GAcy6945PBXhU6C_cPkG7s-rRVGGsXmXSL5yPYC_a7HRKG6kB0LPD3jix7NGbjK0197AnJhaQI1HkEz8I7MGrSn_qKR1Zl6O4z8eB_aOMh7LpnDml7j2CnOzm1j-G6-dHV7ckEropFMYFr0_ls8XbinQNu3_2a_QE3WGaL
linkProvider	Directory of Open Access Journals
openUrl	ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Antimicrobial+resistance+research+in+a+post-pandemic+world%3A+Insights+on+antimicrobial+resistance+research+in+the+COVID-19+pandemic&rft.jtitle=Journal+of+Global+Antimicrobial+Resistance&rft.au=Rodr%C3%ADguez-Ba%C3%B1o%2C+Jes%C3%BAs&rft.au=Rossolini%2C+Gian+Maria&rft.au=Schultsz%2C+Constance&rft.au=Tacconelli%2C+Evelina&rft.date=2021-06-01&rft.issn=2213-7165&rft.volume=25&rft.spage=5&rft.epage=7&rft_id=info:doi/10.1016%2Fj.jgar.2021.02.013&rft.externalDBID=n%2Fa&rft.externalDocID=10_1016_j_jgar_2021_02_013
thumbnail_l	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2213-7165&client=summon
thumbnail_m	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2213-7165&client=summon
thumbnail_s	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2213-7165&client=summon